Literature DB >> 99278

Haemolytic complement in peripheral lymph of normal men.

W L Olszewski, A Engeset.   

Abstract

The haemolytic activity of nine individual components of complement and the concentrations of C1q, C1s, C4, C3, C3PA and C9 proteins were measured in the leg lymph and serum of four normal men. The mean lymph/serum ratio for total haemolytic complement was 0.257, for C1H50 it was 0.138, for C4H50 0.105, for C2H50 0.279, for C3H50 0.063, for C5H50 0.266, for C6H50 0.145, for C7H50 0.25, for C8H50 0.244 and for C9H50 0.253. The mean lymph/serum ratio for complement proteins was: for C1q 0.048, for C1s 0.06, for C4 0.199, for C3 0.225, for C9 0.244 and for C3PA 0.263. The low haemolytic activity of total complement and of all components in lymph seems to be dependent on the low complement protein concentration. The remarkably low lymph C1q protein concentration may play a physiological role in controlling total complement activity in lymph and interstitial fluid. The total complement haemolytic activity in lymph exceeded the haemolytic activity of C1 and C3, which may indicate the possibility of independent activation of C5-7 and C8-9. The considerably low C3H50 level, with high C3 protein concentration, at present lacks a proper explanation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99278      PMCID: PMC1541330     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Concentrating ability of lymphatic vessels.

Authors:  A Taylor; H Gibson
Journal:  Lymphology       Date:  1975-06       Impact factor: 1.286

2.  Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.

Authors:  K NISHIOKA
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

Review 3.  The interaction between intracapillary and tissue forces in the overall regulation of interstitial fluid volume.

Authors:  A E Taylor; W H Gibson; H J Granger; A C Guyton
Journal:  Lymphology       Date:  1973-12       Impact factor: 1.286

4.  Studies in vascular permeability. II. Comparative extravasation of different immunoglobulin classes in normal guinea pig skin.

Authors:  D Jullien-Vitoux; G A Voisin
Journal:  Eur J Immunol       Date:  1973-11       Impact factor: 5.532

5.  Production of the second (C2) and fourth (C4) components of guinea pig complement by single peritoneal cells: evidence that one cell may produce both components.

Authors:  H V Wyatt; H R Colten; T Borsos
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

6.  Reactive haemolysis--a distinctive form of red cell lysis.

Authors:  R A Thompson; D S Rowe
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

7.  Studies on human peripheral lymph. I. Sampling method.

Authors:  A Engeset; B Hager; A Nesheim; A Kolbenstvedt
Journal:  Lymphology       Date:  1973-03       Impact factor: 1.286

8.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

Authors:  D T Fearon; S Ruddy; P H Schur; W R McCabe
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

9.  The dual necessity for delayed hypersensitivity and circulating antibody in the pathogenesis of experimental allergic orchitis in guinea-pigs.

Authors:  P C Brown; L E Glynn; E J Holborow
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

10.  C1r deficiency: an inborn error associated with cutaneous and renal disease.

Authors:  N K Day; H Geiger; R Stroud; M DeBracco; B Mancaido; D Windhorst; R A Good
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

View more
  9 in total

1.  Complement profiles in human skin lymph during the course of irritant contact dermatitis.

Authors:  C U Brand; P J Späth; T Hunziker; A Limat; L R Braathen
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 2.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

3.  Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus.

Authors:  F Moosig; F Damm; A Knorr-Spahr; M Ritgen; R A Zeuner; M Kneba; M Ernst; J O Schröder
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

4.  Serum opsonic activity in acute protein-energy malnutrition.

Authors:  G T Keusch; J J Urrutia; O Guerrero; G Castaneda; H Smith
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 5.  Tissue-targeted complement therapeutics.

Authors:  Stephen Tomlinson; Joshua M Thurman
Journal:  Mol Immunol       Date:  2018-07-07       Impact factor: 4.407

6.  Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

Authors:  Michael Huber; Marek Fischer; Benjamin Misselwitz; Amapola Manrique; Herbert Kuster; Barbara Niederöst; Rainer Weber; Viktor von Wyl; Huldrych F Günthard; Alexandra Trkola
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Different host complement systems and their interactions with saliva from Lutzomyia longipalpis (Diptera, Psychodidae) and Leishmania infantum promastigotes.

Authors:  Antonio Ferreira Mendes-Sousa; Alexandre Alves Sousa Nascimento; Daniel Costa Queiroz; Vladimir Fazito Vale; Ricardo Toshio Fujiwara; Ricardo Nascimento Araújo; Marcos Horácio Pereira; Nelder Figueiredo Gontijo
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

8.  Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.

Authors:  Anna Felberg; Michał Taszner; Aleksandra Urban; Alan Majeranowski; Kinga Jaskuła; Aleksandra Jurkiewicz; Grzegorz Stasiłojć; Anna M Blom; Jan M Zaucha; Marcin Okrój
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

9.  Determination of the critical concentration of neutrophils required to block bacterial growth in tissues.

Authors:  Yongmei Li; Arthur Karlin; John D Loike; Samuel C Silverstein
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.